{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:30:03Z","timestamp":1793446203738,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372881"],"award-info":[{"award-number":["82372881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403698"],"award-info":[{"award-number":["82403698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303655"],"award-info":[{"award-number":["82303655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX1163"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1163"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M740452"],"award-info":[{"award-number":["2023M740452"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.canlet.2025.218146","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:14:09Z","timestamp":1763183649000},"page":"218146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Transglutaminase 2 facilitates metastasis of basal-like bladder cancer by sustaining MVP-mediated MAPK\/ERK1\/2 signaling activation"],"prefix":"10.1016","volume":"636","author":[{"given":"Daihui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7098-0820","authenticated-orcid":false,"given":"Qingshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongya","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.218146_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115545","article-title":"High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy","volume":"44","author":"Xing","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.218146_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.218146_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.218146_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.6062","article-title":"The lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again","volume":"259","author":"H?glund","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.218146_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrurol.2014.129","article-title":"Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer","volume":"11","author":"Choi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2025.218146_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1152\/physrev.00003.2023","article-title":"Tissue transglutaminase: a multifunctional and multisite regulator in health and disease","volume":"104","author":"Yao","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2025.218146_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1152\/physrev.00019.2013","article-title":"Transglutaminase regulation of cell function","volume":"94","author":"Eckert","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2025.218146_bib8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1541-7786.MCR-23-0051","article-title":"Transglutaminase 2 binds to the CD44v6 cytoplasmic domain to stimulate CD44v6\/ERK1\/2 signaling and maintain an aggressive cancer phenotype","volume":"21","author":"Chen","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218146_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mc.23446","article-title":"The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype","volume":"62","author":"Chen","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2025.218146_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43556-022-00079-y","article-title":"Transglutaminase-2 mediates acquisition of neratinib resistance in metastatic breast cancer","volume":"3","author":"Shinde","year":"2022","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.canlet.2025.218146_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-023-06223-y","article-title":"Transglutaminase type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma","volume":"14","author":"Muccioli","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.218146_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12020-023-03427-2","article-title":"Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer","volume":"82","author":"Goksoy Solak","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.canlet.2025.218146_bib13","series-title":"Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica","article-title":"Increased expression of transglutaminase-2 is associated with invasive disease in bladder cancer","author":"Karaca","year":"2025"},{"key":"10.1016\/j.canlet.2025.218146_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.eururo.2021.10.035","article-title":"Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes","volume":"81","author":"Sj?dahl","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.218146_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.218146_bib16","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","article-title":"Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors","volume":"28","author":"Lee","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218146_bib17","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1078-0432.CCR-13-0759","article-title":"Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma","volume":"20","author":"Riester","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218146_bib18","article-title":"Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.canlet.2025.218146_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218146_bib20","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels, brief","volume":"24","author":"Liu","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2025.218146_bib21","doi-asserted-by":"crossref","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.canlet.2025.218146_bib22","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20240493","article-title":"Transglutaminase 2-mediated histone monoaminylation and its role in cancer","volume":"44","author":"Li","year":"2024","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canlet.2025.218146_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1593\/neo.121878","article-title":"Extracellular tissue transglutaminase activates noncanonical NF-\u03baB signaling and promotes metastasis in ovarian cancer","volume":"15","author":"Yakubov","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.218146_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbamcr.2018.11.009","article-title":"Transglutaminase-mediated cross-linking of WDR54 regulates EGF receptor-signaling","volume":"1866","author":"Maeda","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.canlet.2025.218146_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212121","article-title":"MVP expression facilitates tumor cell proliferation and migration supporting the metastasis of colorectal cancer cells","volume":"22","author":"Pietras","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218146_bib26","article-title":"Unraveling the role of major vault protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218146_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417626122","article-title":"Intercellular contractile force attenuates chemosensitivity through Notch-MVP-mediated nuclear drug export","volume":"122","author":"Du","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.218146_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2025.218146_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.2015.66.3468","article-title":"Phase III, double-blind, randomized trial that compared maintenance lapatinib versus placebo after first-line chemotherapy in patients with human epidermal growth factor receptor 1\/2-Positive metastatic bladder cancer","volume":"35","author":"Powles","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218146_bib30","article-title":"The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218146_bib31","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1038\/s41467-024-50678-2","article-title":"Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer","volume":"15","author":"Plumber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218146_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114146","article-title":"Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis","volume":"43","author":"Lee","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.218146_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1485258","article-title":"Transglutaminase 2 in breast cancer metastasis and drug resistance","volume":"12","author":"Li","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.218146_bib34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1073\/pnas.0907907107","article-title":"EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to src activation","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.218146_bib35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3727\/096504018X15149761920868","article-title":"Transglutaminase 2 promotes migration and invasion of lung cancer cells","volume":"26","author":"Lee","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.canlet.2025.218146_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1593\/neo.121878","article-title":"Extracellular tissue transglutaminase activates noncanonical NF-\u03baB signaling and promotes metastasis in ovarian cancer","volume":"15","author":"Yakubov","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.218146_bib37","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1038\/onc.2016.452","article-title":"Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival","volume":"36","author":"Kerr","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218146_bib38","article-title":"Major vault protein (MVP) associated with BRAF (V600E) mutation is an immune microenvironment-related biomarker promoting the progression of papillary thyroid cancer via MAPK\/ERK and PI3K\/AKT pathways","volume":"9","author":"Dong","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.218146_bib39","article-title":"Unraveling the role of major vault protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218146_bib40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1158\/0008-5472.CAN-17-2432","article-title":"Demethylation-induced overexpression of Shc3 drives c-Raf-Independent activation of MEK\/ERK in HCC","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218146_bib41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/onc.2009.342","article-title":"Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells","volume":"29","author":"Jang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.218146_bib42","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/ijc.28623","article-title":"Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways","volume":"134","author":"Kumar","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.218146_bib43","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition via the transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in hepatocellular carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:43:50Z","timestamp":1773812630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525007189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0304383525007189"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218146","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transglutaminase 2 facilitates metastasis of basal-like bladder cancer by sustaining MVP-mediated MAPK\/ERK1\/2 signaling activation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218146"}}